[{"NetIncomeLoss_1_Q2_USD":-55256000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-71000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":8035000.0,"Depreciation_2_Q2_USD":2352000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":84000.0,"AssetsCurrent_0_Q2_USD":616292000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-910000.0,"ContractWithCustomerLiability_0_Q2_USD":89221000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4113469.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":16567000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":526000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":18627000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-25000.0,"CommonStockSharesIssued_0_Q2_shares":68249786.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":698137000.0,"Assets_0_Q2_USD":755880000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":2000.0,"ShareBasedCompensation_2_Q2_USD":25730000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":30314000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":249458000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-5521000.0,"CommonStockSharesAuthorized_0_Q2_shares":195000000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":2000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":6878000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":22027000.0,"MarketableSecuritiesCurrent_0_Q2_USD":272719000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":2077000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":75690000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":33753000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-6016000.0,"ProceedsFromStockPlans_2_Q2_USD":526000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":19000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-1000.0,"CommonStockValue_0_Q2_USD":7000.0,"InvestmentIncomeNet_2_Q2_USD":280000.0,"InvestmentIncomeNet_1_Q2_USD":146000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":43471000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":278553000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-112009000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-55254000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1818000.0,"OtherAssetsNoncurrent_0_Q2_USD":6780000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":337834000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":21282000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1390606000.0,"Liabilities_0_Q2_USD":142519000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":204950000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-5706000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":379000.0,"OperatingIncomeLoss_1_Q2_USD":-55401000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":13000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":13526000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-88436000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":66939967.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":67877126.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":87584000.0,"LiabilitiesCurrent_0_Q2_USD":66016000.0,"AccountsPayableCurrent_0_Q2_USD":4415000.0,"NonoperatingIncomeExpense_2_Q2_USD":299000.0,"NonoperatingIncomeExpense_1_Q2_USD":145000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":13176000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":341711000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":28569000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":914000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_item":0.0,"PreferredStockNoParValue_0_Q2_USD":0.0001,"OperatingLeasePayments_2_Q2_USD":6731000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1079000.0,"ReceivablesNetCurrent_0_Q2_USD":331000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":14910000.0,"NetIncomeLoss_2_Q2_USD":-111984000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5408000.0,"OperatingIncomeLoss_2_Q2_USD":-112283000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":5706000.0,"CommonStockSharesOutstanding_0_Q2_shares":68159786.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":34000000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":755880000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5546000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":25730000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":13526000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":28086000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":8974000.0,"OperatingExpenses_2_Q2_USD":119161000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":194127000.0,"OperatingExpenses_1_Q2_USD":55780000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.67,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.81,"ProfitLoss_2_Q2_USD":-111984000.0,"StockholdersEquity_0_Q2_USD":613361000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":55221000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2788000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":698208000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-777181000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":198152000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-5717000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":9753000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":541000.0,"Ticker":"EDIT","CIK":"1650664","name":"EDITAS MEDICINE, INC.","OfficialName":"Editas Medicine Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1081229362.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]